209 related articles for article (PubMed ID: 19996825)
1. Fundus autofluorescence changes in cytomegalovirus retinitis.
Yeh S; Forooghian F; Faia LJ; Weichel ED; Wong WT; Sen HN; Chan-Kai BT; Witherspoon SR; Lauer AK; Chew EY; Nussenblatt RB
Retina; 2010 Jan; 30(1):42-50. PubMed ID: 19996825
[TBL] [Abstract][Full Text] [Related]
2. Spectral domain optical coherence tomography and fundus autofluorescence findings in cytomegalovirus retinitis in HIV-infected patients.
Yashiro S; Nishijima T; Yamamoto Y; Sekine Y; Yoshida-Hata N; Iida T; Oka S
Jpn J Ophthalmol; 2018 May; 62(3):373-389. PubMed ID: 29445945
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic developments in cytomegalovirus retinitis.
Hoffman VF; Skiest DJ
Expert Opin Investig Drugs; 2000 Feb; 9(2):207-20. PubMed ID: 11060672
[TBL] [Abstract][Full Text] [Related]
4. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
[TBL] [Abstract][Full Text] [Related]
5. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.
Walton RC; Whitcup SM; Mueller BU; Lewis LL; Pizzo PA; Nussenblatt RB
Ophthalmology; 1995 Dec; 102(12):1865-70. PubMed ID: 9098289
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis and treatment of eye diseases associated with HIV infection and AIDS].
Geng S; Ye JJ; Liu LQ; Xu HY; Wang WW; Wang SR
Zhonghua Yan Ke Za Zhi; 2009 Dec; 45(12):1093-8. PubMed ID: 20193432
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of CMV retinitis with intravitreal foscarnet].
Cochereau I; Belayachi N; Diraison C; Matheron S; Bouyer I; Hoang-Xuan T; Saimot AG; Coulaud JP
J Fr Ophtalmol; 1998 Dec; 21(10):723-6. PubMed ID: 10052044
[TBL] [Abstract][Full Text] [Related]
8. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
Arevalo JF; Garcia RA; Mendoza AJ
Eur J Ophthalmol; 2005; 15(5):610-8. PubMed ID: 16167292
[TBL] [Abstract][Full Text] [Related]
9. Treatment of relapsed cytomegalovirus retinitis with the sustained-release ganciclovir implant.
Hatton MP; Duker JS; Reichel E; Morley MG; Puliafito CA
Retina; 1998; 18(1):50-5. PubMed ID: 9502281
[TBL] [Abstract][Full Text] [Related]
10. Intraocular therapy for cytomegalovirus retinitis.
Palestine AG
J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus retinitis associated with acquired immunodeficiency syndrome.
Geng S; Ye JJ; Zhao JL; Li TS; Han Y
Chin Med J (Engl); 2011 Apr; 124(8):1134-8. PubMed ID: 21542985
[TBL] [Abstract][Full Text] [Related]
12. Treatment of bilateral cytomegalovirus retinitis with sustained-release ganciclovir implants in a child.
Malley DS; Barone R; Heinemann MH
Am J Ophthalmol; 1996 Nov; 122(5):731-2. PubMed ID: 8909217
[TBL] [Abstract][Full Text] [Related]
13. High-dose intravitreal ganciclovir and foscarnet for cytomegalovirus retinitis.
Velez G; Roy CE; Whitcup SM; Chan CC; Robinson MR
Am J Ophthalmol; 2001 Mar; 131(3):396-7. PubMed ID: 11239885
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus Retinitis in Three Pediatric Cases with Acute Lymphoblastic Leukemia: Case Series and Review of the Literature.
Demir SÖ; Çeliker H; Karaaslan A; Kadayifci EK; Akkoç G; Atıcı S; Yakut N; Şenay E; Kazokoğlu H; Koç A; Bakır M; Soysal A
Jpn J Infect Dis; 2016 Nov; 69(6):534-538. PubMed ID: 26567834
[TBL] [Abstract][Full Text] [Related]
15. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
Ophthalmology; 1994 Jul; 101(7):1250-61. PubMed ID: 8035989
[TBL] [Abstract][Full Text] [Related]
16. Chronic retinal necrosis: cytomegalovirus necrotizing retinitis associated with panretinal vasculopathy in non-HIV patients.
Schneider EW; Elner SG; van Kuijk FJ; Goldberg N; Lieberman RM; Eliott D; Johnson MW
Retina; 2013 Oct; 33(9):1791-9. PubMed ID: 23584702
[TBL] [Abstract][Full Text] [Related]
17. Advances in treatment for cytomegalovirus retinitis.
Bowers M
BETA; 1995 Sep; ():13-5. PubMed ID: 11362885
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal ganciclovir for cytomegalovirus retinitis in patients with AIDS.
Montero MC; Pastor M; Buenestado C; Lluch A; Atienza M
Ann Pharmacother; 1996; 30(7-8):717-23. PubMed ID: 8826547
[TBL] [Abstract][Full Text] [Related]
19. Treatment of clinically resistant cytomegalovirus retinitis with combined intravitreal injections of ganciclovir and foscarnet.
Desatnik HR; Foster RE; Lowder CY
Am J Ophthalmol; 1996 Jul; 122(1):121-3. PubMed ID: 8659587
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of ganciclovir versus foscarnet in ganciclovir-resistant cytomegalovirus retinitis: A case report.
Lee HJ; Woo SJ
Eur J Ophthalmol; 2023 Sep; 33(5):NP105-NP108. PubMed ID: 36314436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
